34
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Hematopoietic Stem Cell Transplants for Multiple Myeloma

, , , , , & show all
Pages 25-36 | Received 20 Sep 1995, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sh. Jerjis, S. Croockewit, F. Preijers, N. Schaap & T. de Witte. (2000) Impact of Chemotherapy on the Mobilisation, Harvest and Economic Costs of Autologous Peripheral Stem Cell Transplantation in Patients with Multiple Myeloma. Leukemia & Lymphoma 37:5-6, pages 551-560.
Read now
Robert G. Hawley & Lloyd C. Berger. (1998) Growth Control Mechanisms in Multiple Myeloma. Leukemia & Lymphoma 29:5-6, pages 465-475.
Read now

Articles from other publishers (12)

Jooeun Bae, Mehmet Samur, Paul Richardson, Nikhil C. Munshi & Kenneth C. Anderson. (2019) Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy. Leukemia 33:9, pages 2208-2226.
Crossref
Sharmilan Thanendrarajan, Faith E Davies, Gareth J Morgan, Carolina Schinke, Pankaj Mathur, Christoph J Heuck, Maurizio Zangari, Joshua Epstein, Shmuel Yaccoby, Niels Weinhold, Bart Barlogie & Frits van Rhee. (2016) Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?. Immunotherapy 8:3, pages 367-384.
Crossref
Jooeun Bae, Nikhil C. Munshi & Kenneth C. Anderson. (2014) Immunotherapy Strategies in Multiple Myeloma. Hematology/Oncology Clinics of North America 28:5, pages 927-943.
Crossref
Jooeun Bae, R. H. Prabhala & Nikhil C. Munshi. 2013. Advances in Biology and Therapy of Multiple Myeloma. Advances in Biology and Therapy of Multiple Myeloma 131 154 .
Morie A. Gertz, Shaji Kumar, Martha Q. Lacy, Angela Dispenzieri, David Dingli, Suzanne R. Hayman, Francis K. Buadi & William J. Hogan. (2010) Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction. Blood 115:12, pages 2348-2353.
Crossref
Jumei Shi, Guido Tricot, Susann Szmania, Nancy Rosen, Tarun K. Garg, Priyangi A. Malaviarachchi, Amberly Moreno, Bo DuPont, Katharine C. Hsu, Lee Ann Baxter-Lowe, Michele Cottler-Fox, John D. Shaughnessy Jr, Bart Barlogie & Frits van Rhee. (2008) Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation. British Journal of Haematology 143:5, pages 641-653.
Crossref
M. Kneba, M. Brüggemann, U. Keilholz, T. Lion, G. Dölken, K. Pantel & A. Zoubek. 2006. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie 383 427 .
Bronwen E. Shaw, Karl Peggs, Jennifer M. Bird, Jamie Cavenagh, A. Hunter, J. Alejandro Madrigal, Nigel H. Russell, Bhawna Sirohi, Keiren Towlson, Catherine D. Williams & David I. Marks. (2003) The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. British Journal of Haematology 123:5, pages 886-895.
Crossref
K. Remes, M. Itälä, M. Kauppila, T.-T. Pelliniemi & A. Rajamäki. (2003) Autologous Blood Cell Transplantation in Multiple Myeloma: Impact of CD34 + Cell Selection with Long Follow-Up . Journal of Hematotherapy & Stem Cell Research 12:1, pages 63-70.
Crossref
Elizabeth Ann Coleman, Sharon K. Coon, Sandra G. Mattox & Patricia O?Sullivan. (2002) Symptom Management and Successful Outpatient Transplantation for Patients With Multiple Myeloma. Cancer Nursing 25:6, pages 452-460.
Crossref
S. Vincent Rajkumar, Morie A. Gertz, Robert A. Kyle & Philip R. Greipp. (2002) Current Therapy for Multiple Myeloma. Mayo Clinic Proceedings 77:8, pages 813-822.
Crossref
Julia Almeida, Alberto Orfao, Mauricio Ocqueteau, Gema Mateo, Mercedes Corral, Ma Delores Caballero, Joan Blade, Ma Jesus Moro, Jose Hernandez & Jesus F. San Miguel. (2008) High‐sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma. British Journal of Haematology 107:1, pages 121-131.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.